╲ ╲ ╲ ╲ ╲
· · · · · · · ·
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
APEA PMHNP
CERTIFICATION EXAM
2026/2027 EDITION
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Independent Study Questions | NGN-Inspired Cases & Rationales
◆ ◇ ◆
· · · · · · ·
◆
PMHNP Certification Study Resource • 2026/2027 | 1
,Section 1: Brief Introduction
This independently authored 200-item PMHNP certification study bank reviews assessment,
diagnosis, psychopharmacology, psychotherapy, safety, lifespan care, ethics, and care
coordination, with case-based and NGN-inspired clinical-judgment prompts. APEA provides
exam-preparation education; certification exams are administered by ANCC or AANPCB, and this
resource is not an official, authenticated, or endorsed exam and does not reproduce live exam
questions.
Section 2: The Complete Exam
Select the single best answer. Some stems are case-based or NGN-inspired; answers and concise
rationales are integrated for study.
1. [Psychopharm • Application] A patient with panic disorder uses alprazolam daily and
requests an early refill after escalating doses. Best response? Which response best reflects
sound PMHNP clinical judgment?
A. Refill at a higher dose without assessment
B. Assess use, dependence, withdrawal and safety; avoid abrupt cessation and develop
a monitored treatment plan
C. Tell the patient to stop immediately
D. Add alcohol to reduce panic
Rationale: Benzodiazepines can cause tolerance, dependence, and dangerous withdrawal; assess and taper if
indicated while treating the underlying disorder. The key is to assess the relevant risk and context before
choosing or changing treatment.
2. [Therapy] A patient with PTSD is hesitant to discuss trauma details. A trauma-informed
approach is to:
A. Prioritize safety, choice, collaboration, and control; do not pressure disclosure
B. Require a detailed trauma narrative at the first visit
C. Interpret reluctance as resistance
D. Promise that therapy will eliminate all symptoms
Rationale: Trauma-informed care avoids retraumatization and supports choice, trust, collaboration, and
empowerment.
3. [Assessment • Application] An adult reports chronic inattention. Before diagnosing
ADHD, the clinician should establish: Which plan is most appropriate to discuss with the
patient?
A. Inattention is present only during a depressive episode
B. A positive screening scale alone is sufficient
C. Symptoms began last week after a medication change
PMHNP Certification Study Resource • 2026/2027 | 2
, D. Symptoms began in childhood, occur in more than one setting, impair function, and
are not better explained by another condition
Rationale: ADHD is neurodevelopmental; developmental history, cross-setting impairment, collateral data,
and differential diagnosis are important. The best choice balances evidence, patient safety, shared decision-
making, and follow-up.
4. [Systems/EBP] An outcome measure indicates no improvement after an adequate trial.
The PMHNP should:
A. Continue indefinitely without review
B. Assume the patient is resistant
C. Review the treatment target, measurement, adherence, dose, duration, diagnosis,
and options with the patient
D. Change several medications at once without rationale
Rationale: Measurement-based care guides reassessment; verify an adequate trial and shared goals before
changing treatment.
5. [Psychopharm • Application] A patient taking sertraline develops fever, agitation,
diaphoresis, diarrhea, hyperreflexia, and clonus after adding linezolid. Priority? Which
response best reflects sound PMHNP clinical judgment?
A. Increase sertraline
B. Treat as ordinary SSRI nausea
C. Wait for symptoms to resolve at home
D. Stop serotonergic agents as directed and arrange emergency evaluation for
serotonin toxicity
Rationale: Clonus and autonomic/neuromuscular findings suggest serotonin syndrome, a potentially life-
threatening interaction requiring urgent care. The key is to assess the relevant risk and context before
choosing or changing treatment.
6. [Psychopharm • Application] A patient on a dopamine-blocking antipsychotic develops
lip smacking and tongue movements after long-term use. Best response? Which next step
best supports safe, evidence-informed care?
A. Increase the antipsychotic dose automatically
B. Reassure that this is acute dystonia
C. Add an anticholinergic without assessment
D. Assess for tardive dyskinesia with a structured tool and review treatment options
Rationale: Orofacial movements may be tardive dyskinesia; use structured assessment and consider risk-
benefit options, including VMAT2 inhibitors when appropriate. The selected action follows the clinical risk
and avoids premature assumptions or unsafe delay.
7. [Legal/ethical] A PMHNP is asked to provide care outside their competence.
Appropriate action?
A. Proceed without support
PMHNP Certification Study Resource • 2026/2027 | 3
, B. Misrepresent credentials
C. Seek consultation, supervision, or referral while ensuring continuity and urgent
safety needs
D. Abandon the patient
Rationale: Clinicians must practice within competence and arrange consultation/referral without
abandoning patients.
8. [Assessment • Application] An older adult develops new hallucinations and cognitive
changes after a medication change. Best first step? Which response best reflects sound
PMHNP clinical judgment?
A. Review medications and medical causes, assess cognition and safety, and obtain
collateral history
B. Diagnose late-onset schizophrenia immediately
C. Assume normal aging
D. Start several psychotropics simultaneously
Rationale: New late-life symptoms warrant evaluation for delirium, neurocognitive, medication, and medical
causes before a primary psychiatric diagnosis. The key is to assess the relevant risk and context before
choosing or changing treatment.
9. [Clinical case/NGN] A patient with major depression has psychomotor retardation, poor
intake, and inability to care for self. The PMHNP should:
A. Assess severity, medical stability, suicide risk, and need for urgent or higher-level
care
B. Offer routine follow-up in six months
C. Focus only on sleep hygiene
D. Diagnose adjustment disorder
Rationale: Marked functional decline and poor intake may require urgent intervention and higher level of
care, with safety and medical assessment.
10. [Psychopharm] A patient taking a stimulant has new chest pain and marked
hypertension. The clinician should:
A. Increase the dose
B. Reassure that chest pain is expected
C. Hold further stimulant and urgently assess cardiovascular symptoms
D. Add another stimulant
Rationale: Stimulants can raise heart rate and blood pressure; chest pain is a potentially serious adverse
event requiring urgent evaluation.
11. [Psychopharm] A patient with opioid use disorder wants treatment. Which response
reflects evidence-based care?
A. Require abstinence from all medication before treatment
B. Offer counseling only as the sole option
PMHNP Certification Study Resource • 2026/2027 | 4
· · · · · · · ·
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
APEA PMHNP
CERTIFICATION EXAM
2026/2027 EDITION
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Independent Study Questions | NGN-Inspired Cases & Rationales
◆ ◇ ◆
· · · · · · ·
◆
PMHNP Certification Study Resource • 2026/2027 | 1
,Section 1: Brief Introduction
This independently authored 200-item PMHNP certification study bank reviews assessment,
diagnosis, psychopharmacology, psychotherapy, safety, lifespan care, ethics, and care
coordination, with case-based and NGN-inspired clinical-judgment prompts. APEA provides
exam-preparation education; certification exams are administered by ANCC or AANPCB, and this
resource is not an official, authenticated, or endorsed exam and does not reproduce live exam
questions.
Section 2: The Complete Exam
Select the single best answer. Some stems are case-based or NGN-inspired; answers and concise
rationales are integrated for study.
1. [Psychopharm • Application] A patient with panic disorder uses alprazolam daily and
requests an early refill after escalating doses. Best response? Which response best reflects
sound PMHNP clinical judgment?
A. Refill at a higher dose without assessment
B. Assess use, dependence, withdrawal and safety; avoid abrupt cessation and develop
a monitored treatment plan
C. Tell the patient to stop immediately
D. Add alcohol to reduce panic
Rationale: Benzodiazepines can cause tolerance, dependence, and dangerous withdrawal; assess and taper if
indicated while treating the underlying disorder. The key is to assess the relevant risk and context before
choosing or changing treatment.
2. [Therapy] A patient with PTSD is hesitant to discuss trauma details. A trauma-informed
approach is to:
A. Prioritize safety, choice, collaboration, and control; do not pressure disclosure
B. Require a detailed trauma narrative at the first visit
C. Interpret reluctance as resistance
D. Promise that therapy will eliminate all symptoms
Rationale: Trauma-informed care avoids retraumatization and supports choice, trust, collaboration, and
empowerment.
3. [Assessment • Application] An adult reports chronic inattention. Before diagnosing
ADHD, the clinician should establish: Which plan is most appropriate to discuss with the
patient?
A. Inattention is present only during a depressive episode
B. A positive screening scale alone is sufficient
C. Symptoms began last week after a medication change
PMHNP Certification Study Resource • 2026/2027 | 2
, D. Symptoms began in childhood, occur in more than one setting, impair function, and
are not better explained by another condition
Rationale: ADHD is neurodevelopmental; developmental history, cross-setting impairment, collateral data,
and differential diagnosis are important. The best choice balances evidence, patient safety, shared decision-
making, and follow-up.
4. [Systems/EBP] An outcome measure indicates no improvement after an adequate trial.
The PMHNP should:
A. Continue indefinitely without review
B. Assume the patient is resistant
C. Review the treatment target, measurement, adherence, dose, duration, diagnosis,
and options with the patient
D. Change several medications at once without rationale
Rationale: Measurement-based care guides reassessment; verify an adequate trial and shared goals before
changing treatment.
5. [Psychopharm • Application] A patient taking sertraline develops fever, agitation,
diaphoresis, diarrhea, hyperreflexia, and clonus after adding linezolid. Priority? Which
response best reflects sound PMHNP clinical judgment?
A. Increase sertraline
B. Treat as ordinary SSRI nausea
C. Wait for symptoms to resolve at home
D. Stop serotonergic agents as directed and arrange emergency evaluation for
serotonin toxicity
Rationale: Clonus and autonomic/neuromuscular findings suggest serotonin syndrome, a potentially life-
threatening interaction requiring urgent care. The key is to assess the relevant risk and context before
choosing or changing treatment.
6. [Psychopharm • Application] A patient on a dopamine-blocking antipsychotic develops
lip smacking and tongue movements after long-term use. Best response? Which next step
best supports safe, evidence-informed care?
A. Increase the antipsychotic dose automatically
B. Reassure that this is acute dystonia
C. Add an anticholinergic without assessment
D. Assess for tardive dyskinesia with a structured tool and review treatment options
Rationale: Orofacial movements may be tardive dyskinesia; use structured assessment and consider risk-
benefit options, including VMAT2 inhibitors when appropriate. The selected action follows the clinical risk
and avoids premature assumptions or unsafe delay.
7. [Legal/ethical] A PMHNP is asked to provide care outside their competence.
Appropriate action?
A. Proceed without support
PMHNP Certification Study Resource • 2026/2027 | 3
, B. Misrepresent credentials
C. Seek consultation, supervision, or referral while ensuring continuity and urgent
safety needs
D. Abandon the patient
Rationale: Clinicians must practice within competence and arrange consultation/referral without
abandoning patients.
8. [Assessment • Application] An older adult develops new hallucinations and cognitive
changes after a medication change. Best first step? Which response best reflects sound
PMHNP clinical judgment?
A. Review medications and medical causes, assess cognition and safety, and obtain
collateral history
B. Diagnose late-onset schizophrenia immediately
C. Assume normal aging
D. Start several psychotropics simultaneously
Rationale: New late-life symptoms warrant evaluation for delirium, neurocognitive, medication, and medical
causes before a primary psychiatric diagnosis. The key is to assess the relevant risk and context before
choosing or changing treatment.
9. [Clinical case/NGN] A patient with major depression has psychomotor retardation, poor
intake, and inability to care for self. The PMHNP should:
A. Assess severity, medical stability, suicide risk, and need for urgent or higher-level
care
B. Offer routine follow-up in six months
C. Focus only on sleep hygiene
D. Diagnose adjustment disorder
Rationale: Marked functional decline and poor intake may require urgent intervention and higher level of
care, with safety and medical assessment.
10. [Psychopharm] A patient taking a stimulant has new chest pain and marked
hypertension. The clinician should:
A. Increase the dose
B. Reassure that chest pain is expected
C. Hold further stimulant and urgently assess cardiovascular symptoms
D. Add another stimulant
Rationale: Stimulants can raise heart rate and blood pressure; chest pain is a potentially serious adverse
event requiring urgent evaluation.
11. [Psychopharm] A patient with opioid use disorder wants treatment. Which response
reflects evidence-based care?
A. Require abstinence from all medication before treatment
B. Offer counseling only as the sole option
PMHNP Certification Study Resource • 2026/2027 | 4
